Eagle’s Eye View: Redefining CV Subspecialty Training
In this week’s View, Dr. Eagle looks at a recent article on proposed changes to the current cardiovascular (CV) subspecialty training path. He then examines an article on a novel left atrium (LA) staging framework that stratifies new-onset atrial fibrillation risk in hypertrophic cardiomyopathy (HCM). Finally, Dr. Eagle explores the results of a Look AHEAD ancillary study on the inflammatory biomarker interleukin (IL)-6 that identified residual inflammatory risk of incident heart failure (HF) in patients with type 2 diabetes (T2D) and overweight/obesity.
X Links:
- Kim Eagle, MD, MACC keaglemd
Clinical Topics: Arrhythmias and Clinical EP, Cardiovascular Care Team, Heart Failure and Cardiomyopathies, Valvular Heart Disease, Atrial Fibrillation/Supraventricular Arrhythmias, Acute Heart Failure, Heart Failure and Cardiac Biomarkers, Acute Coronary Syndromes
Keywords: Education, Workforce, Health Educators, Education, Medical, Graduate, Education, Graduate, Physician Executives, Cardiomyopathy, Hypertrophic, Familial, Ventricular Dysfunction, Left, Heart Atria, Atrial Fibrillation, Cardiomyopathy, Hypertrophic, Diabetes Mellitus, Type 2, Incretins, C-Reactive Protein, Overweight, Biomarkers, Inflammation, Weight Loss, Heart Failure, Obesity
